Organic Revenue Growth*(1) 8% Approximately 4% Free Cash Flow* $1.7 billion ~$1.8 billion | --- | --- | --- | |-----------------------|-------|----------------------------------| | Adjusted EBIT Margin* | 15.1% | 15.6% - 15.9% 50 - 80 bps growth | | Adjusted ETR* 23.7% | | 23% - 25% | | Adjusted EPS* | $3.93 | $4.20 - $4.35 7% - 11% growth | © 2024 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. 13 Investing in Digital for Future Growth Imaging Ultrasound Imaging A ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2023 Earnings Conference Call February 6, 2024 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Graham Doyle - UBS Anthony Petrone - Mizuho Patrick Wood - ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

GE HealthCare Technologies (GEHC) reported $5.21 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 5.4%. EPS of $1.18 for the same period compares to $1.31 a year ago.The reported revenue represents a surprise of +2.21% over the Zacks Consensus Estimate of $5.09 billion. With the consensus EPS estimate being $1.07, the EPS surprise was +10.28%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.28%. A quarter ago, it was expected that this medical technology company would post earnings of $0.89 per share when it actually produced earnings of $0.99, delivering a surprise of 11.24%.Over the la ...

GE HealthCare Technologies Inc.’s stock GEHC, -0.68% rose 0.9% early Tuesday, after the company posted better-than-expected profit and revenue for the fourth quarter, offsetting soft guidance for 2024. GE HealthCare, which was spun out of General Electric Co. in January of 2023 and houses its medical device business, posted net income of $403 million, or 88 cents a share, for the quarter, down from $554 million, or $1.21 a share, in the year-earlier period. Adjusted per-share earnings came to $1.18, ahead ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the fourth quarter ended December 31, 2023. GE HealthCare President and CEO Peter Arduini said, “After our first year as a publicly traded company, I’m pleased to announce robust fourth quarter and full year results. This strong financial performance is a testament to our dedicated team and successful execution of our precision care strategy. We’ve made significant strides ...

Financial Position and Debt - The company has approximately $9,442 million in outstanding borrowings as of December 31, 2023[243]. - As of December 31, 2023, the company has $8,250 million of fixed-rate debt and $1,150 million outstanding on a Term Loan Facility with a variable interest rate[383]. - A hypothetical change of interest rates by 100 basis points would increase or decrease the company's annual interest expense by approximately $22 million[384]. - The company entered into interest-rate swap contracts in Q4 2023 to convert $1,000 million of senior unsecured notes from fixed rates to variable rates as part of its interest rate risk management strategy[385]. Operational Risks and Challenges - The company may incur increased costs due to the loss of synergies previously enjoyed while operating as part of GE[240]. - The company may face challenges accessing capital markets on favorable terms due to potential volatility and disruptions[242]. - Disruptions in deliveries or production, due to various risks, could significantly impact the company's operating profit or cash flows[388]. Currency and Commodity Exposure - A potential 10% decrease in USD spot rates against other currencies could result in a $13 million decrease in the fair value of foreign currency derivative contracts[380]. - The company has exposure to foreign currency translation risk due to global operations, with significant revenues and expenses in various currencies[378]. - If commodity or energy prices increase and the company cannot pass these costs to customers, profit margins would be adversely affected[387]. - The company relies on supplies of raw materials such as helium, iodine, and rare earth minerals, which are subject to volatility in demand, availability, and pricing[386]. Shareholder Impact and Equity - Future equity issuances may dilute existing shareholders' interests and adversely affect earnings per share[250]. - GE owns approximately 13.5% of the company's outstanding common stock and intends to monetize its remaining ownership over time[249]. Compliance and Internal Controls - The company is required to comply with Section 404 of the Sarbanes Oxley Act, which mandates annual management assessments of internal control effectiveness[239]. - The company’s ability to generate cash is subject to various external factors, including economic and regulatory conditions[245]. Deferred Compensation and Equity Risks - The company has $269 million of deferred compensation liabilities subject to equity price risk, which would impact earnings and cash flows[390]. - The company entered into various transaction agreements with GE related to the Spin-Off, which may impact its financial condition if obligations are not met[241].

GE HealthCare Technologies Inc. (GEHC) is scheduled to report fourth-quarter 2023 results on Feb 6, before market open.In the last reported quarter, the company’s adjusted earnings per share of 99 cents surpassed the Zacks Consensus Estimate by 11.2%.Let’s take a look at how things might have shaped up prior to the announcement.Factors at PlayIn January 2023, General Electric Company announced the completion of the spinoff of its healthcare business to create a new player in the field of Precision Care. Fro ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Novii™+ Wireless Patch Solution. The antepartum and intrapartum maternal and fetal monitor noninvasively measures and displays fetal heart rate, maternal heart rate and uterine activity, so care teams can have a real-time view of patient data. Through its belt-free and wireless design, Novii+ enables mobility and freedom for mothers to support ...